Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
出版年份 2015 全文链接
标题
Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
作者
关键词
-
出版物
JOURNAL OF GENERAL VIROLOGY
Volume 96, Issue 11, Pages 3265-3279
出版商
Microbiology Society
发表日期
2015-09-10
DOI
10.1099/jgv.0.000278
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recognition determinants of broadly neutralizing human antibodies against dengue viruses
- (2015) Alexander Rouvinski et al. NATURE
- Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
- (2015) Monica Poggianella et al. PLoS Neglected Tropical Diseases
- Climate change and dengue: a critical and systematic review of quantitative modelling approaches
- (2014) Suchithra Naish et al. BMC INFECTIOUS DISEASES
- Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
- (2014) U. N. Sarwar et al. JOURNAL OF INFECTIOUS DISEASES
- Virus-Like Particle Secretion and Genotype-Dependent Immunogenicity of Dengue Virus Serotype 2 DNA Vaccine
- (2014) J. U. Galula et al. JOURNAL OF VIROLOGY
- A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- (2014) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- New Tags for Recombinant Protein Detection and O-Glycosylation Reporters
- (2014) Gianluca Petris et al. PLoS One
- Characterization of the Ectodomain of the Envelope Protein of Dengue Virus Type 4: Expression, Membrane Association, Secretion and Particle Formation in the Absence of Precursor Membrane Protein
- (2014) Szu-Chia Hsieh et al. PLoS One
- Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines
- (2014) Eakachai Prompetchara et al. PLoS One
- Chaperone fusion proteins aid entropy-driven maturation of class II viral fusion proteins
- (2014) Peng Ge et al. TRENDS IN MICROBIOLOGY
- Relating structure to evolution in class II viral membrane fusion proteins
- (2014) Yorgo Modis Current Opinion in Virology
- Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization
- (2013) R. Saenz et al. MOLECULAR IMMUNOLOGY
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Burden of dengue fever is higher than previously thought
- (2013) A. Gulland BMJ-British Medical Journal
- Mutagenesis of the DI/DIII Linker in Dengue Virus Envelope Protein Impairs Viral Particle Assembly
- (2012) M. de Wispelaere et al. JOURNAL OF VIROLOGY
- Structure of a Dengue Virus Envelope Protein Late-Stage Fusion Intermediate
- (2012) D. E. Klein et al. JOURNAL OF VIROLOGY
- Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice
- (2012) Xueling Li et al. MICROBES AND INFECTION
- Dengue
- (2012) Cameron P. Simmons et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins
- (2012) Wen-Yang Tsai et al. PLoS One
- Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
- (2012) Katherine L. Williams et al. VIROLOGY
- Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
- (2012) Hong-En Lin et al. PLoS Neglected Tropical Diseases
- Novel Strategies to Improve DNA Vaccine Immunogenicity
- (2011) Cevayir Coban et al. CURRENT GENE THERAPY
- Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells
- (2011) S. Zompi et al. JOURNAL OF IMMUNOLOGY
- A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
- (2011) Julie E. Ledgerwood et al. JOURNAL OF INFECTIOUS DISEASES
- DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III
- (2011) Adriana S. Azevedo et al. PLoS One
- Development of dengue DNA vaccines
- (2011) Janine R. Danko et al. VACCINE
- The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
- (2011) Beth-Ann G. Coller et al. VACCINE
- Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion
- (2011) Siritorn Butrapet et al. VIROLOGY
- The Human Antibody Response to Dengue Virus Infection
- (2011) Wahala M. P. B. Wahala et al. Viruses-Basel
- In Vitro Reconstitution Reveals Key Intermediate States of Trimer Formation by the Dengue Virus Membrane Fusion Protein
- (2010) M. Liao et al. JOURNAL OF VIROLOGY
- Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
- (2010) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation
- (2010) Dorothy Beckett et al. PROTEIN SCIENCE
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection
- (2010) Danielle Malta Lima et al. VACCINE
- Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
- (2010) Charmagne G. Beckett et al. VACCINE
- Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes
- (2010) Steven M. Erb et al. VIROLOGY
- Immature Dengue Virus: A Veiled Pathogen?
- (2010) Izabela A. Rodenhuis-Zybert et al. PLoS Pathogens
- In Vitro and In Vivo Studies Identify Important Features of Dengue Virus pr-E Protein Interactions
- (2010) Aihua Zheng et al. PLoS Pathogens
- Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease
- (2009) Scott C. Weaver et al. INFECTION GENETICS AND EVOLUTION
- Development of a novel DNA SynCon™ tetravalent dengue vaccine that elicits immune responses against four serotypes
- (2009) Mathura P. Ramanathan et al. VACCINE
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge
- (2008) Sérgio Oliveira De Paula et al. ARCHIVES OF VIROLOGY
- In vivo site-specific biotinylation of proteins within the secretory pathway using a single vector system
- (2008) Andrea Predonzani et al. BMC BIOTECHNOLOGY
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
- (2008) Theodore C. Pierson et al. Cell Host & Microbe
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
- Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
- (2008) Shee-Mei Lok et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation
- (2008) L. Li et al. SCIENCE
- Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III
- (2008) Kiyohiko Matsui et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now